Flush With Cash, Adaptive Biotech Hires Former Zillow CFO

Three months after raising $195 million, Seattle’s Adaptive Biotechnologies has a new chief financial officer to manage all that cash. The company said Monday it has hired Chad Cohen, the former CFO of real estate information firm Zillow Group, also based in Seattle. Cohen joined Adaptive’s board in March. Adaptive specializes in sequencing the cells in the human adaptive immune system, which are constantly shuffling their genes to combat threats. According to Adaptive, former CFO Dean Schorno is leaving to pursue a job in the San Francisco Bay Area, where he lives.

Author: Alex Lash

I've spent nearly all my working life as a journalist. I covered the rise and fall of the dot-com era in the second half of the 1990s, then switched to life sciences in the new millennium. I've written about the strategy, financing and scientific breakthroughs of biotech for The Deal, Elsevier's Start-Up, In Vivo and The Pink Sheet, and Xconomy. View all posts by Alex Lash